Orca Capital AG, a German company, filed a Schedule 13G with the SEC on November 17, 2026, disclosing beneficial ownership of 2,023,602 Class A Ordinary Shares of Lichen International Limited following a registered offering completed on November 10, 2026.
Key Highlights
- Beneficial ownership: Orca Capital AG reported beneficial ownership of 2,023,602 Class A Ordinary Shares of Lichen International Limited.
- Percent of class: The 2,023,602 shares represent 9.9% of the class, according to the filing.
- Sole voting and dispositive power: Orca Capital AG holds sole voting power and sole dispositive power over all 2,023,602 shares, with no shared voting or dispositive power reported.
- Share count basis: The 9.9% figure is calculated based on 20,216,825 ordinary shares outstanding immediately after completion of the issuer's registered offering, as stated in the filing.
- Warrants excluded: The filing states that 8,526,398 ordinary shares issuable upon exercise of common warrants and 6,950,000 ordinary shares issuable upon exercise of pre-funded warrants are excluded from the ownership calculation, subject to the 9.99% Blocker.
- Triggering event: The filing identifies November 10, 2026 as the date of the event requiring the statement, coinciding with the issuer's Prospectus Supplement filed pursuant to Rule 424(b)(5).
Orca Capital AG Reports Position in Lichen International After November 2026 Offering
According to the Schedule 13G filed on November 17, 2026, Orca Capital AG, organized in Germany and headquartered at Sperlring 2, 85276 Hettenshausen, Deutschland, disclosed that it beneficially owns 2,023,602 Class A Ordinary Shares of Lichen International Limited (NASDAQ:LICN), a company whose principal executive offices are located at 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013. The shares carry a par value of US$0.008 per share and are identified by CUSIP number G5479G116.
The filing states that all ownership percentages are calculated based upon an aggregate of 20,216,825 ordinary shares outstanding immediately after giving effect to the completion of the issuer's registered offering, as provided in a Prospectus Supplement filed with the SEC on November 10, 2026. The filing further states that the percentage excludes 8,526,398 ordinary shares issuable upon the exercise of common warrants and 6,950,000 ordinary shares issuable upon the exercise of pre-funded warrants, each subject to the 9.99% Blocker. Pursuant to the terms of the common warrants, the filing discloses that Orca Capital AG "cannot exercise any of the warrants to the extent the Reporting Person would beneficially own, after any such exercise, more than 9.99% of the Issuer's outstanding ordinary shares."
The filing was signed by Thomas Konig in his capacity as Director of Orca Capital AG. The certifications included in the filing state that, to the best of the filer's knowledge and belief, the securities "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities."
What Was Disclosed
Orca Capital AG filed a Schedule 13G disclosing a 9.9% beneficial ownership position of 2,023,602 Class A Ordinary Shares in Lichen International Limited, with sole voting and dispositive power over all reported shares, triggered by the issuer's registered offering completed on November 10, 2026.


Please wait processing your request...